Aura Biosciences, Inc. presents Logo
  • Aura Biosciences, Inc. presents

  • A New Potential Option for Uveal Melanoma – The Science of Bel-Sar and Phase 3 CoMpass Trial

  • July 17, 2024 7:15am Stockholmsmassan, room A2

    Last Registration Day - July 15, 2024
  • Attendee Information

    Please fill name and contact information.
  • This program is not affiliated with or endorsed by the ASRS.

  • Should be Empty: